专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

61. 发明申请

US20020077488A1 Methods for the preparation of 4-hydroxy benzothiophene 失效
标题翻译： 4-羟基苯并噻吩的制备方法
公开(公告)号：US20020077488A1
公开(公告)日：2002-06-20
申请号：US10008877
申请日：2001-11-08
发明人： Bernd Junghans , Michelangelo Scalone , Thomas Albert Zeibig
IPC分类号： C07F009/6553 , C07D333/04 , C07D333/12 , C07D333/16
CPC分类号： C07D333/54 , C07D417/14
摘要： The present invention is concerned with a novel process for the preparation of a hydroxybenzothiophene that is an intermediate for synthesizing pharmaceutically active substances, e.g. 5- null4-null2-(5-methyl-2-phenyl-4-oxazolyl)ethoxynull-7-benzothiophenylmethylnull-2,4-thiazolidinedione and the corresponding sodium salt which are useful in the treatment of diabetes.
摘要翻译：本发明涉及一种制备羟基苯并噻吩的新方法，该羟基苯并噻吩是用于合成药物活性物质的中间体，例如， 5- [4- [2-（5-甲基-2-苯基-4-恶唑基）乙氧基] -7-苯并噻吩基甲基] -2,4-噻唑烷二酮及其相应的钠盐可用于治疗糖尿病。

62. 发明申请

US20020013351A1 Compounds possessing neuronal activity 有权
标题翻译：化合物具有神经元活性
公开(公告)号：US20020013351A1
公开(公告)日：2002-01-31
申请号：US09815193
申请日：2001-06-27
申请人： VERTEX PHARMACEUTICALS INCORPORATED
发明人： Patricia McCaffrey , Perry M. Novak , Michael Mullican
IPC分类号： A61K031/44 , C07D333/12 , C07D333/20 , A61K031/42 , A61K031/425 , A61K031/4164 , A61K031/415
CPC分类号： C07D213/40 , C07D211/60 , C07D401/12 , C07D401/14
摘要： The present invention relates to compounds, methods and pharmaceutical compositions for stimulating the growth of neurites in nerve cells. The compounds and the compositions and methods that utilize them can be used, either alone or in conjunction with a neurotrophic factor, such as nerve growth factor, to promote repair of neuronal damage caused by disease or physical trauma.
摘要翻译：本发明涉及用于刺激神经细胞中神经突生长的化合物，方法和药物组合物。使用它们的化合物和组合物和方法可以单独使用或与神经营养因子如神经生长因子联合使用，以促进由疾病或身体创伤引起的神经元损伤的修复。

63. 发明授权

US5883125A Benzyloxy substituted aromatics and their use as fungicides and insecticides 失效
标题翻译：苄氧基取代的芳族化合物及其作为杀真菌剂和杀虫剂的用途
公开(公告)号：US5883125A
公开(公告)日：1999-03-16
申请号：US857375
申请日：1997-06-02
申请人： Ronald Ross , Ted Tsutomu Fujimoto , Steven Howard Shaber
发明人： Ronald Ross , Ted Tsutomu Fujimoto , Steven Howard Shaber
IPC分类号： C07D239/26 , A01N37/38 , A01N37/50 , A01N43/08 , A01N43/10 , A01N43/40 , A01N43/48 , A01N43/60 , C07C69/734 , C07C69/736 , C07C69/738 , C07C235/34 , C07C251/48 , C07D207/33 , C07D213/38 , C07D213/50 , C07D215/12 , C07D217/02 , C07D237/08 , C07D241/12 , C07D261/10 , C07D271/02 , C07D307/38 , C07D333/12 , C07D333/22 , A01N37/10
CPC分类号： A01N43/40 , A01N37/38 , A01N37/50 , A01N43/10 , C07C251/48 , C07C69/736 , C07D213/50 , C07D333/22 , C07C2101/02 , C07C2101/08 , C07C2101/14
摘要： Compounds with fungicidal and insecticidal properties having formula I ##STR1## wherein A is N or CH; V is O or NH; m and n are integers 0 and 1 provided that m+n is 1;X is independently selected from hydrogen, halo, (C.sub.1 -C.sub.4)alkyl, and (C.sub.1 -C.sub.4) alkoxy;R is independently selected from, (C.sub.1 -C.sub.12)alkyl, halo(C.sub.1 -C.sub.12)alkyl, (C.sub.2 -C.sub.8) alkenyl, (C.sub.2 -C.sub.8)alkynyl, (C.sub.1 -C.sub.12)alkoxy(C.sub.1 -C.sub.12)alkyl, (C.sub.3 -C.sub.7) cycloalkyl, (C.sub.3 -C.sub.7)cycloalkyl(C.sub.1 -C.sub.4)alkyl, aryl, aralkyl, and heterocyclic moieties;R is independently selected from (C.sub.1 -C.sub.12)alkyl, halo(C.sub.1 -C.sub.12)alkyl, (C.sub.2 -C.sub.8) alkenyl, (C.sub.2 -C.sub.8)alkynyl, (C.sub.1 -C.sub.12)alkoxy(C.sub.1 -C.sub.12)alkyl, (C.sub.3 -C.sub.7) cycloalkyl, (C.sub.3 -C.sub.7)cycloalkyl(C.sub.1 -C.sub.4)alkyl, aryl, aralkyl, and heterocyclic;R.sub.1 and R.sub.2 are independently selected from hydrogen, (C.sub.1 -C.sub.6)alkyl, halo(C.sub.1 -C.sub.12) alkyl, (C.sub.3 -C.sub.7)cycloalkyl, (C.sub.3 -C.sub.7)cycloalkyl(C.sub.1 -C.sub.4)alkyl, cyano, carboxy(C.sub.1 -C.sub.4)alkyl, and aryl; provided at least one of R.sub.1 and R.sub.2 is H.
摘要翻译：具有式I的具有杀真菌性和杀虫性的化合物其中A为N或CH; V为O或NH; m和n为整数0和1，条件是m + n为1; X独立地选自氢，卤代（C1-C4）烷基和（C1-C4）烷氧基; R独立地选自（C1-C12）烷基，卤代（C1-C12）烷基，（C2-C8）烯基，（C2-C8）（C 1 -C 12）烷基，（C 3 -C 7）环烷基，（C 3 -C 7）环烷基（C 1 -C 4）烷基，芳基，芳烷基和杂环部分; R独立地选自（C 1 -C 12） -C 1 -C 12）烷基，（C 1 -C 12）烷基，（C 2 -C 8）烯基，（C 2 -C 8）炔基，（C 1 -C 12）烷氧基（C 1 -C 12）烷基，（C 3 -C 7） C 1 -C 6烷基，（C 1 -C 12）烷基，（C 3 -C 7）环烷基，（C 3 -C 7）环烷基， -C 7）环烷基（C 1 -C 4）烷基，氰基，羧基（C 1 -C 4）烷基和芳基;提供R 1和R 2中的至少一个为H.

64. 发明授权

US5710140A Phenyl heterocycles as COX-2 inhibitors 失效
公开(公告)号：US5710140A
公开(公告)日：1998-01-20
申请号：US699142
申请日：1996-08-16
申请人： Yves Ducharme , Jacques Yves Gauthier , Petpiboon Prasit , Yves Leblanc , Zhaoyin Wang , Serge Leger , Michel Therien
发明人： Yves Ducharme , Jacques Yves Gauthier , Petpiboon Prasit , Yves Leblanc , Zhaoyin Wang , Serge Leger , Michel Therien
IPC分类号： C07D333/06 , A61K31/00 , A61K31/10 , A61K31/12 , A61K31/122 , A61K31/18 , A61K31/19 , A61K31/255 , A61K31/34 , A61K31/341 , A61K31/35 , A61K31/351 , A61K31/365 , A61K31/38 , A61K31/381 , A61K31/395 , A61K31/40 , A61K31/4015 , A61K31/425 , A61K31/426 , A61K31/66 , A61P1/00 , A61P1/02 , A61P1/04 , A61P7/04 , A61P11/06 , A61P15/00 , A61P17/02 , A61P19/00 , A61P19/02 , A61P21/00 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/16 , A61P35/00 , A61P43/00 , C07C20060101 , C07C13/08 , C07C13/10 , C07C305/18 , C07C307/02 , C07C311/15 , C07C311/16 , C07C311/29 , C07C311/37 , C07C311/46 , C07C311/49 , C07C311/51 , C07C317/10 , C07C317/24 , C07C323/29 , C07D207/26 , C07D207/333 , C07D207/38 , C07D207/444 , C07D207/448 , C07D275/02 , C07D277/02 , C07D277/22 , C07D277/24 , C07D277/26 , C07D307/33 , C07D307/38 , C07D307/58 , C07D309/32 , C07D333/04 , C07D333/12 , C07D333/16 , C07D333/18 , C07D333/24 , C07D333/38 , C07D333/40 , C07D405/04 , C07D407/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D503/04 , C07F9/40 , C07F9/547 , C07F9/572 , C07F9/6506 , C07F9/653 , C07F9/6539 , C07F9/655 , A61K31/675 , C07F9/02
CPC分类号： C07D275/02 , C07C311/29 , C07C311/46 , C07C311/49 , C07C317/24 , C07D277/26 , C07D307/38 , C07D307/58 , C07D333/18 , C07D333/38 , C07D405/04 , C07C2101/08
摘要： The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

65. 发明授权

US5663367A 2,4-pentadienoic acid derivatives having retinoid-like biological activity 失效
标题翻译：具有类视黄醇样生物活性的2,4-戊二烯酸衍生物
公开(公告)号：US5663367A
公开(公告)日：1997-09-02
申请号：US656137
申请日：1996-05-31
申请人： Vidyasagar Vuligonda , Roshantha A. Chandraratna
发明人： Vidyasagar Vuligonda , Roshantha A. Chandraratna
IPC分类号： A61K31/35 , A61K31/20 , A61K31/23 , A61K31/38 , A61K31/47 , A61P17/00 , A61P43/00 , C07C57/50 , C07C69/618 , C07C215/02 , C07C215/18 , C07C311/58 , C07C335/06 , C07C403/00 , C07D277/22 , C07D311/58 , C07D333/54 , C07D335/06 , C07D333/12 , C07D307/40 , C07D307/56 , C07D333/22
CPC分类号： C07D333/54 , A61K31/20 , A61K31/23 , C07C57/50 , C07C69/618 , C07D311/58 , C07D335/06
摘要： Compounds of Formula 1 ##STR1## wherein Z is selected from the group consisting of the radicals shown in Formula 2 and in Formula 3, ##STR2## Y is cycloalkyl or cycloalkenyl of 3 to 8 carbons optionally substituted with one or two R.sub.4 groups, or Y is selected from phenyl, pyridyl, thienyl, furyl, pyrrolyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, oxazolyl, and imidazolyl, said groups being optionally substituted with one or two R.sub.4 groups, the divalent Y radical being substituted by the Z and --CR.sub.1 .dbd.CR.sub.1 --CR.sub.1 .dbd.CR.sub.1 groups on adjacent carbons; X is S, O, or NR.sub.5 ; n is 1 or 2; R.sub.1 and R.sub.2 independently are H, lower alkyl or fluoroalkyl; R.sub.3 is hydrogen, lower alkyl, Cl or Br; R.sub.4 is lower alkyl, fluoroalkyl or halogen; R.sub.5 is H or lower alkyl, and B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR.sub.8, CONR.sub.9 R.sub.10, --CH.sub.2 OH, CH.sub.2 OR.sub.11, CH.sub.2 OCOR.sub.11, CHO, CH(OR.sub.12).sub.2, CHOR.sub.13 O, --COR.sub.7, CR.sub.7 (OR.sub.12).sub.2, CR.sub.7 OR.sub.13 O, or tri-lower alkylsilyl, where R.sub.7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R.sub.8 is an alkyl group of 1 to 10 carbons, a cycloalkyl group of 5 to 10 carbons or trimethylsilylalkyl where the alkyl group has 1 to 10 carbons, or R.sub.8 is phenyl or lower alkylphenyl, R.sub.9 and R.sub.10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl or lower alkylphenyl, R.sub.11 is lower alkyl, phenyl or lower alkylphenyl, R.sub.12 is lower alkyl, and R.sub.13 is divalent alkyl radical of 2-5 carbons, have retinoid like biological activity.
摘要翻译：式1的化合物其中Z选自由式2和式3所示的基团组成的组。式3 Y是3至8个碳的环烷基或环烯基，任选地被一个或两个R 4基取代，或Y选自苯基，吡啶基，噻吩基，呋喃基，吡咯基，哒嗪基，嘧啶基，吡嗪基，噻唑基，恶唑基和咪唑基，所述基团任选被一个或两个R 4基团取代，二价 Y基团被相邻碳上的Z和-CR1 = CR1-CR1 = CR1基团取代; X是S，O或NR5; n为1或2; R1和R2独立地为H，低级烷基或氟代烷基; R3是氢，低级烷基，Cl或Br; R4是低级烷基，氟烷基或卤素; R 5是H或低级烷基，B是氢，COOH或其药学上可接受的盐，COOR8，CONR9R10，-CH2OH，CH2OR11，CH2OCOR11，CHO，CH（OR12）2，CHOR13O，-COR7，CR7（OR12） CR 7OR 13 O或三低级烷基甲硅烷基，其中R 7为含有1至5个碳的烷基，环烷基或烯基，R 8为碳原子数1至10的烷基，碳原子数为5至10的环烷基或烷基具有的三甲基甲硅烷基烷基 1至10个碳，或R8为苯基或低级烷基苯基，R9和R10独立地为氢，1-10个碳原子的烷基或5-10个碳原子的环烷基，或苯基或低级烷基苯基，R11为低级烷基，苯基或低级烷基苯基，R12为低级烷基，R13为2-5个碳原子的二价烷基，具有类视黄醇类生物活性。

66. 发明授权

US5536752A Phenyl heterocycles as COX-2 inhibitors 失效
标题翻译：苯基杂环作为COX-2抑制剂
公开(公告)号：US5536752A
公开(公告)日：1996-07-16
申请号：US436672
申请日：1995-05-08
申请人： Yves Ducharme , Jacques Y. Gauthier , Petpiboon Prasit , Yves Leblanc , Zhaoyin Wang , Serge Leger , Michel Therien
发明人： Yves Ducharme , Jacques Y. Gauthier , Petpiboon Prasit , Yves Leblanc , Zhaoyin Wang , Serge Leger , Michel Therien
IPC分类号： C07D333/06 , A61K31/00 , A61K31/10 , A61K31/12 , A61K31/122 , A61K31/18 , A61K31/19 , A61K31/255 , A61K31/34 , A61K31/341 , A61K31/35 , A61K31/351 , A61K31/365 , A61K31/38 , A61K31/381 , A61K31/395 , A61K31/40 , A61K31/4015 , A61K31/425 , A61K31/426 , A61K31/66 , A61P1/00 , A61P1/02 , A61P1/04 , A61P7/04 , A61P11/06 , A61P15/00 , A61P17/02 , A61P19/00 , A61P19/02 , A61P21/00 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/16 , A61P35/00 , A61P43/00 , C07C20060101 , C07C13/08 , C07C13/10 , C07C305/18 , C07C307/02 , C07C311/15 , C07C311/16 , C07C311/29 , C07C311/37 , C07C311/46 , C07C311/49 , C07C311/51 , C07C317/10 , C07C317/24 , C07C323/29 , C07D207/26 , C07D207/333 , C07D207/38 , C07D207/444 , C07D207/448 , C07D275/02 , C07D277/02 , C07D277/22 , C07D277/24 , C07D277/26 , C07D307/33 , C07D307/38 , C07D307/58 , C07D309/32 , C07D333/04 , C07D333/12 , C07D333/16 , C07D333/18 , C07D333/24 , C07D333/38 , C07D333/40 , C07D405/04 , C07D407/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D503/04 , C07F9/40 , C07F9/547 , C07F9/572 , C07F9/6506 , C07F9/653 , C07F9/6539 , C07F9/655
CPC分类号： C07D275/02 , C07C311/29 , C07C311/46 , C07C311/49 , C07C317/24 , C07D277/26 , C07D307/38 , C07D307/58 , C07D333/18 , C07D333/38 , C07D405/04 , C07C2101/08
摘要： The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
摘要翻译：本发明包括可用于治疗环氧合酶-2介导的疾病的新颖的式I化合物。本发明还包括用于治疗环氧合酶-2介导的疾病的某些药物组合物，其包含式I化合物。

67. 发明授权

US5474995A Phenyl heterocycles as cox-2 inhibitors 失效
标题翻译：苯基杂环作为cox-2抑制剂
公开(公告)号：US5474995A
公开(公告)日：1995-12-12
申请号：US179467
申请日：1994-01-10
申请人： Yves Ducharme , Jacques Y. Gauthier , Petpiboon Prasit , Yves Leblanc , Zhaoyin Wang , Serge Leger , Michel Therien
发明人： Yves Ducharme , Jacques Y. Gauthier , Petpiboon Prasit , Yves Leblanc , Zhaoyin Wang , Serge Leger , Michel Therien
IPC分类号： C07D333/06 , A61K31/00 , A61K31/10 , A61K31/12 , A61K31/122 , A61K31/18 , A61K31/19 , A61K31/255 , A61K31/34 , A61K31/341 , A61K31/35 , A61K31/351 , A61K31/365 , A61K31/38 , A61K31/381 , A61K31/395 , A61K31/40 , A61K31/4015 , A61K31/425 , A61K31/426 , A61K31/66 , A61P1/00 , A61P1/02 , A61P1/04 , A61P7/04 , A61P11/06 , A61P15/00 , A61P17/02 , A61P19/00 , A61P19/02 , A61P21/00 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/16 , A61P35/00 , A61P43/00 , C07C20060101 , C07C13/08 , C07C13/10 , C07C305/18 , C07C307/02 , C07C311/15 , C07C311/16 , C07C311/29 , C07C311/37 , C07C311/46 , C07C311/49 , C07C311/51 , C07C317/10 , C07C317/24 , C07C323/29 , C07D207/26 , C07D207/333 , C07D207/38 , C07D207/444 , C07D207/448 , C07D275/02 , C07D277/02 , C07D277/22 , C07D277/24 , C07D277/26 , C07D307/33 , C07D307/38 , C07D307/58 , C07D309/32 , C07D333/04 , C07D333/12 , C07D333/16 , C07D333/18 , C07D333/24 , C07D333/38 , C07D333/40 , C07D405/04 , C07D407/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D503/04 , C07F9/40 , C07F9/547 , C07F9/572 , C07F9/6506 , C07F9/653 , C07F9/6539 , C07F9/655 , A61K31/53 , C07D307/02
CPC分类号： C07D275/02 , C07C311/29 , C07C311/46 , C07C311/49 , C07C317/24 , C07D277/26 , C07D307/38 , C07D307/58 , C07D333/18 , C07D333/38 , C07D405/04 , C07C2101/08
摘要： The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases, ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
摘要翻译：本发明包括可用于治疗环氧合酶-2介导的疾病的新颖的式I化合物。本发明还包括用于治疗包含式I化合物的环加氧酶-2介导的疾病的某些药物组合物。

68. 发明授权

US5354776A Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid-like activity 失效
标题翻译：用杂芳族基团和四氢化萘基二取代并具有类视黄醇样活性的乙炔
公开(公告)号：US5354776A
公开(公告)日：1994-10-11
申请号：US84843
申请日：1993-06-29
申请人： Roshantha A. S. Chandraratna
发明人： Roshantha A. S. Chandraratna
IPC分类号： C07D237/08 , A61K31/34 , A61K31/341 , A61K31/38 , A61K31/381 , A61K31/44 , A61K31/4418 , A61K31/495 , A61P17/00 , A61P27/02 , A61P27/14 , A61P29/00 , A61P37/08 , C07D213/06 , C07D213/30 , C07D213/48 , C07D213/50 , C07D213/55 , C07D213/65 , C07D213/80 , C07D213/81 , C07D237/24 , C07D239/26 , C07D239/28 , C07D241/12 , C07D241/24 , C07D307/54 , C07D307/68 , C07D333/12 , C07D333/14 , C07D333/24 , C07D307/42 , C07D307/46
CPC分类号： C07D213/80
摘要： Retinoid-like activity is exhibited by compounds of the formula ##STR1## where R is hydrogen or lower alkyl; A is pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl or pyrazinyl; n is 0-5; and B is H, --COOH or an ester or amide thereof, --CH.sub.2 OH or an ether or ester derivative thereof, or --CHO or an acetal derivative thereof, or --COR.sub.1 or a ketal derivative thereof where R.sub.1 is --(CH.sub.2).sub.m CH.sub.3 where m is 0-4; or a pharmaceutically acceptable salt thereof.
摘要翻译：类视黄醇样活性由式（Ⅰ）的化合物表现，其中R是氢或低级烷基; A是吡啶基，噻吩基，呋喃基，哒嗪基，嘧啶基或吡嗪基; n为0-5; 和B是H，-COOH或其酯或酰胺，-CH 2 OH或其醚或酯衍生物，或-CHO或其缩醛衍生物，或-COR1或其缩酮衍生物，其中R1是 - （CH2）mCH3，其中 m为0-4; 或其药学上可接受的盐。

69. 发明授权

US4981868A Pharmaceutically active 3-heteroaryl-2-fluoro-1-olefins 失效
标题翻译：药学活性3-杂芳基-2-氟-1-烯烃
公开(公告)号：US4981868A
公开(公告)日：1991-01-01
申请号：US384944
申请日：1989-07-25
申请人： James R. McCarthy , Donald P. Matthews , Charlotte L. Barney
发明人： James R. McCarthy , Donald P. Matthews , Charlotte L. Barney
IPC分类号： A61K31/05 , A61K31/047 , A61K31/085 , A61K31/38 , A61K31/381 , A61P9/12 , A61P43/00 , C07C17/00 , C07C25/24 , C07C37/62 , C07C39/373 , C07C41/22 , C07C43/225 , C07C391/02 , C07D333/12 , C07D333/28
CPC分类号： C07C39/373 , C07C391/02 , C07C43/225 , C07D333/28
摘要： This invention relates to novel 3-heteroaryl-2-fluoro-1-olefins and their pharmacological use as dopamine beta-hydroxylase DBH inhibitors in the treatment of DBH mediated conditions such as hypertension.

70. 发明授权

US4978386A Herbicidal 2-(substituted-phenyl)-3-amino-2-cyclopentenone derivatives 失效
标题翻译：除草2-（取代苯基）-3-氨基-2-环戊烯酮衍生物
公开(公告)号：US4978386A
公开(公告)日：1990-12-18
申请号：US794345
申请日：1985-10-31
申请人： Carl E. Ward
发明人： Carl E. Ward
IPC分类号： A01N35/06 , A01N35/02 , A01N37/34 , A01N37/44 , A01N43/02 , A01N43/10 , A01N43/36 , C07C67/00 , C07C213/00 , C07C227/00 , C07C227/08 , C07C253/00 , C07C313/00 , C07C323/25 , C07C323/31 , C07C323/60 , C07D295/10 , C07D307/52 , C07D333/12 , C07D333/22 , C07D333/24
CPC分类号： A01N35/02 , A01N43/10 , C07D333/22
摘要： 2-(3-substituted phenyl)-3-amino-2-cyclopentenone derivatives. The compounds generally exhibit both pre-emergence and post-emergence phytotoxicity and are useful as herbicides and also at low dosages as plant growth regulating agents.
摘要翻译： 2-（3-取代苯基）-3-氨基-2-环戊烯酮衍生物。化合物通常表现出芽前和芽后植物毒性，并且可用作除草剂，并且以低剂量用作植物生长调节剂。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式